Skip to main content
Lincoln Pharmaceuticals ltd. logo

Lincoln Pharmaceuticals ltd. — Investor Relations & Filings

Ticker · LINCOLN ISIN · INE405C01035 LEI · 3358004B6OBJNW8RTT10 BSE.NS Manufacturing
Filings indexed 453 across all filing types
Latest filing 2022-02-10 Regulatory Filings
Country IN India
Listing BSE.NS LINCOLN

About Lincoln Pharmaceuticals ltd.

https://www.lincolnpharma.com/

Lincoln Pharmaceuticals Ltd. focuses on the development, manufacturing, and marketing of a diverse range of therapeutic formulations. The organization operates advanced manufacturing facilities certified by international standards, including WHO-GMP. Its portfolio spans multiple areas such as anti-infectives, cardiovascular, gastrointestinal, respiratory, and pain management. The company is recognized for its research and development initiatives, particularly in Novel Drug Delivery Systems (NDDS). Key offerings include specialized treatments for tinnitus and a wide array of formulations in dosage forms like tablets, capsules, liquid orals, and injectables. It maintains a significant global footprint, supplying products to numerous international markets across Africa, Southeast Asia, and Latin America, supported by a robust distribution network for its extensive healthcare catalog.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2022-02-10 English
Outcome of Board Meeting
Regulatory Filings
2022-02-10 English
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document contains only references to omitted pictures and has a very short length (378 characters). There is no textual content indicating any report, announcement, or detailed information. Given the lack of substantive content and the presence of placeholders for images only, this document does not represent a full report or detailed filing. It is most consistent with a Regulatory Filing (RNS) as a fallback category for miscellaneous or incomplete filings.
2022-02-02 English
Updates
Regulatory Filings
2022-01-19 English
Updates
Regulatory Filings Classification · 95% confidence The document contains only references to omitted pictures and no textual content or substantive information. It is extremely short (485 characters) and does not contain any financial data, regulatory references, or report content. Given the lack of content, it cannot be classified as a substantive report or announcement. It fits best as a Regulatory Filing (RNS) which is the fallback category for miscellaneous filings without clear classification.
2022-01-07 English
Updates
Regulatory Filings
2021-11-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.